Big pharma may have genomic tool vendors to thank in part for a recent surge in R&D productivity — and it could return the favor with greater technology investment.

After declining more than 20 percent from the mid-1990s to the early-2000s, the rate at which new candidates at the 10 biggest drug makers entered clinical testing has increased 52 percent in recent years, according to a report released last week from the Tufts Center for the Study of Drug Development.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.